Qi Zhong

NHC Key Laboratory Of Diagnosis And Treatment On Brain Functional Diseases
Chongqing, 400016, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Esketamine alleviates depressive-like behavior in mice via modulation of the microbiota-gut-brain axis and amino acid metabolism.

Esketamine alleviates depressive-like behavior in mice via modulation of the microbiota-gut-brain axis and amino acid metabolism.

Journal: BMC microbiology

Published: April 15, 2025

Fecal metabolites as early-phase biomarkers and prediction panel for ischemic stroke.

Fecal metabolites as early-phase biomarkers and prediction panel for ischemic stroke.

Journal: BMC microbiology

Published: January 30, 2025

Caffeine plays a prevention role in stress-induced depression by modulating gut-brain axis function.

Caffeine plays a prevention role in stress-induced depression by modulating gut-brain axis function.

Journal: European journal of pharmacology

Published: December 07, 2024

Consistent decline of acetylcholine in microbiota-gut-brain axis mediates antibiotic-induced anxiety via regulating hippocampus microglial activation.

Consistent decline of acetylcholine in microbiota-gut-brain axis mediates antibiotic-induced anxiety via regulating hippocampus microglial activation.

Journal: Molecular psychiatry

Published: November 20, 2024

Limosilactobacillus-related 3-OMDP as a potential therapeutic target for depression.

Limosilactobacillus-related 3-OMDP as a potential therapeutic target for depression.

Journal: Annals of medicine

Published: October 18, 2024

Chronic administration of isotretinoin induces depressive- and anxiety-like behaviors by altering the neuroactive ligand-receptor interaction pathway in adolescent mice.

Chronic administration of isotretinoin induces depressive- and anxiety-like behaviors by altering the neuroactive ligand-receptor interaction pathway in adolescent mice.

Journal: Translational psychiatry

Published: September 11, 2024

Elevated SCN11A concentrations associated with lower serum lipid levels in patients with major depressive disorder.

Elevated SCN11A concentrations associated with lower serum lipid levels in patients with major depressive disorder.

Journal: Translational psychiatry

Published: November 01, 2023

IDH2/PPARγ pathway as a novel diagnostic biomarker panel for schizophrenia.

IDH2/PPARγ pathway as a novel diagnostic biomarker panel for schizophrenia.

Journal: Asian journal of psychiatry

Published: July 03, 2023

TCF4 and RBFOX1 as peripheral biomarkers for the differential diagnosis and treatment of major depressive disorder.

TCF4 and RBFOX1 as peripheral biomarkers for the differential diagnosis and treatment of major depressive disorder.

Journal: Journal of affective disorders

Published: April 26, 2023

LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study.

LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study.

Journal: Translational psychiatry

Published: January 09, 2023

Tryptophan metabolism as bridge between gut microbiota and brain in chronic social defeat stress-induced depression mice.

Tryptophan metabolism as bridge between gut microbiota and brain in chronic social defeat stress-induced depression mice.

Journal: Frontiers in cellular and infection microbiology

Published: December 12, 2022

Differential Gut Microbiota Compositions Related With the Severity of Major Depressive Disorder.

Differential Gut Microbiota Compositions Related With the Severity of Major Depressive Disorder.

Journal: Frontiers in cellular and infection microbiology

Published: April 06, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026